Literature DB >> 3827225

Brain extraction of a calcium channel blocker.

J C Grotta, L C Pettigrew, A H Lockwood, C Reid, C Reich.   

Abstract

Dihydropyridine calcium channel blockers may be effective treatment for acute cerebral ischemia, but the uptake of these drugs into the brain is unknown. A 0.2-ml bolus of [14C]nicardipine hydrochloride and [3H]water was injected into the common carotid arteries of 7 normal and 7 ischemic rats. The corrected first-pass extraction of nicardipine, compared to water, was calculated to be 30.7% into the hemispheres and 42.3% into the hippocampi. The uptake was greater into the ischemic hemispheres (p less than 0.001). These data suggest that dihydropyridines are available to binding sites and calcium channels in neurons.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827225     DOI: 10.1002/ana.410210209

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.

Authors:  Lucy Colbourne; Paul J Harrison
Journal:  Mol Psychiatry       Date:  2022-05-26       Impact factor: 15.992

2.  Effects of nicardipine treatment on Na(+)-K+ ATPase and lipid peroxidation after experimental subarachnoid haemorrhage.

Authors:  F Marzatico; P Gaetani; G Spanu; E Buratti; R Rodriguez y Baena
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

3.  The effect of lifarizine (RS-87476), a novel sodium and calcium channel modulator, on ischaemic dopamine depletion in the corpus striatum of the gerbil.

Authors:  C M Brown; C Calder; B J Alps; M Spedding
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.